《新英格兰医药杂志》.2006年.第22期

　

• The Cambridge History of Medicine
• The Body Hunters: Testing New Drugs on the World's Poorest Patients
• Imatinib Mesylate, Increased Bone Formation, and Secondary Hyperparathyroidism
• Medical Mystery: Visual-Field Defect — The Answer
• The Value of Medical Spending in the United States
• Risk Score for Predicting Death in Chagas' Heart Disease
• Klebsiella oxytoca as a Causative Organism of Antibiotic-Associated Hemorrhagic Colitis
• Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia
• Coronary Intervention for Persistent Occlusion after Myocardial Infarction
• Exploring the Uses of RNAi — Gene Knockdown and the Nobel Prize
• The Ethics and Politics of Compulsory HPV Vaccination
• Medicine: Perspectives in History and Art
• Treatment of Rectal Cancer
• Drug-Eluting Stents in Primary PCI
• Another Look at Imatinib Mesylate
• Thiazolidinediones for Initial Treatment of Type 2 Diabetes?
• Myocardial Infarction and the Open-Artery Hypothesis
• Sum of the Parts
• Medical Mystery — Abnormal Abdominal Radiograph
• The Myeloproliferative Disorders
• Peginterferon and Ribavirin for Chronic Hepatitis C
• Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy
• A Medical Mystery — Arthritis
• Ambulatory Blood-Pressure Monitoring
• Panic Disorder
• Unintended Consequences of Caps on Medicare Drug Benefits
• Body-Mass Index and Symptoms of Gastroesophageal Reflux in Women
• Outcomes of In-Hospital Ventricular Fibrillation in Children
• Cost Sharing, Caps on Benefits, and the Chronically Ill — A Policy Mismatch
• Accuracy or Outcome in Suspected Pulmonary Embolism
• Thinking outside the Box
• The Endocrine System in Sports and Exercise
• Bleeding Blue and Gray: Civil War Surgery and the Evolution of American Medicine
• Searching the Medical Literature
• Itopride for Functional Dyspepsia
• Denosumab in Postmenopausal Women with Low Bone Mineral Density
• Thalidomide for Multiple Myeloma
• Natalizumab for Relapsing Multiple Sclerosis
• Multidetector Computed Tomography for Acute Pulmonary Embolism
• Medicare Part D — The Product of a Broken Process
• The First Months of the Prescription-Drug Benefit — A CMS Update
• Life-Threatening Malfunction of Implantable Cardiac Devices